GN enters partnership to detect cognitive impairment in people with hearing loss

Hearing aid group GN is joining forces with US-based Sonde Health to develop vocal biomarkers to aid in the early detection and management of life-threatening diseases for millions of hearing loss patients.

Photo: GN Store Nord / PR

Hearing aid group GN Store Nord, which is based in Denmark, has signed a multi-year strategic partnership with US-based company Sonde Health. Together, they will research and develop commercial vocal biomarkers for mild cognitive impairment, reports a press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs